Rolfe M, Beer-Romero P, Glass S, Eckstein J, Berdo I, Theodoras A, Pagano M, Draetta G
Mitotix Inc., Cambridge, MA 02139, USA.
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3264-8. doi: 10.1073/pnas.92.8.3264.
The E6 protein of the high-risk human papillomaviruses inactivates the tumor suppressor protein p53 by stimulating its ubiquitinylation and subsequent degradation. Ubiquitinylation is a multistep process involving a ubiquitin-activating enzyme, one of many distinct ubiquitin-conjugating enzymes, and in certain cases, a ubiquitin ligase. In human papillomavirus-infected cells, E6 and the E6-associated protein are thought to act as a ubiquitin-protein ligase in the ubiquitinylation of p53. Here we describe the cloning of a human ubiquitin-conjugating enzyme that specifically ubiquitinylates E6-associated protein. Furthermore, we define the biochemical pathway of p53 ubiquitinylation and demonstrate that in vivo inhibition of various components in the pathway leads to an inhibition of E6-stimulated p53 degradation.
高危型人乳头瘤病毒的E6蛋白通过刺激肿瘤抑制蛋白p53的泛素化及随后的降解,使其失活。泛素化是一个多步骤过程,涉及一种泛素激活酶、众多不同泛素结合酶中的一种,在某些情况下还涉及一种泛素连接酶。在人乳头瘤病毒感染的细胞中,E6和E6相关蛋白被认为在p53的泛素化过程中作为一种泛素-蛋白连接酶发挥作用。在此,我们描述了一种特异性泛素化E6相关蛋白的人泛素结合酶的克隆。此外,我们确定了p53泛素化的生化途径,并证明在体内抑制该途径中的各种成分会导致对E6刺激的p53降解的抑制。